An open trial of oral sildenafil in antidepressant-induced sexual dysfunction

Psychotherapy and Psychosomatics

Volumn 67, Issue 6, 1998, Pages 328-331

  Fava, Maurizio ^a   Rankin, Meridith A ^a   Alpert, Jonathan E ^a   Nierenberg, Andrew A ^a   Worthington, John J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Antidepressants; Depression; Sexual dysfunction; Sildenafil

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CLONAZEPAM; FLUOXETINE; FLUVOXAMINE; METHYLPHENIDATE; MIRTAZAPINE; NEFAZODONE; PAROXETINE; PHOSPHODIESTERASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; TRAZODONE; VALPROIC ACID;

ADULT; AROUSAL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HOT FLUSH; HUMAN; LIBIDO; MALE; ORAL DRUG ADMINISTRATION; ORGASM; OUTPATIENT; PATIENT SATISFACTION; PENIS ERECTION; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SEXUALITY; STATISTICAL ANALYSIS;

EID: 0031729374     PISSN: 00333190     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012299     Document Type: Article

References (26)

1. Lane RM: A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J Psychopharmacol 1997;11:72-82.
2. Smith DM, Levitte SS: Association of fluoxetine and return of sexual potency in three elderly men. J Clin Psychiatry 1993;54:317-319.
3. Margolese HC, Assalian P: Sexual side effects of antidepressants: A review. J Sex Marital Ther 1996;22:209-217.
4. Fava M, Rosenbaum JF: Treatment-emergent side effects of the new antidepressants; in The Psychiatric Clinics of North America: Annual of Drug Therapy, vol 3; 1996, pp 13-29.
5. Shen WW, Hsu JH: Female sexual side effects associated with selective serotonin reuptake inhibitors: A descriptive clinical study of 33 patients. Int J Psychiatry Med 1995;25:239-248.
6. Jacobsen FM: Fluoxetine-induced sexual dysfunction and an open trial of yohimbine. J Clin Psychiatry 1992;53:119-122.
7. Zajecka J, Mitchell S, Fawcett J: Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol Bull 1997;33:755-760.
8. Montejo AI, Llorca G, Izquierdo JA, Ledesma A, Bousono M, Calcedo A, Carrasco, Daniel E, de Dios A, de la Gandara J, Franco M, Gomez MJ, Macias JA, Martin T, Perez V, Sanchez JM, Sanchez S, Vicens E: Sexual dysfunction secondary to SSRIs: A comparative analysis in 308 patients. Actos Luso Esp Neurol Psiquiatr Ciencias Afines 1996;24:311-321.
9. Fava M, Amsterdam JD, Deltito JA, Salzman C, Schwaller M, Dunner DL: A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry, in press.
10. Rothschild AJ: Selective serotonin reuptake inhibitor-induced sexual dysfunction: Efficacy of a drug holiday. Am J Psychiatry 1995;152: 151-156.
11. Labbate LA, Pollack MH: Treatment of fluoxetine-induced sexual dysfunction with bupropion: A case report. Ann Clin Psychiatry 1994; 6:13-15.
12. Norden MJ: Buspirone treatment of sexual dysfunction associated with selective serotonin reuptake inhibitors. Depression 1994;2:109-112.
13. Gitlin MJ: Treatment of sexual side effects with dopaminergic agents. J Clin Psychiatry 1995;56:124.
14. Balon R: Intermittent amantadine for fluoxetine-induced anorgasmia. J Sex Marital Ther 1996;22:290-292.
15. Gross MD: Reversal by bethanechol of sexual dysfunction caused by anticholinergic antide-pressants. Am J Psychiatry 1982;139:1193-1194.
16. Lauerma H: Successful treatment of citalopram-induced anorgasmia by cyproheptadine. Acta Psychiatr Scand 1996;93:69-70.
17. Feder R: Reversal of Antidepressant activity of fluoxetine by cyproheptadine in three patients. J Clin Psychiatry 1991;52:163-164.
18. Price J, Grunhaus LJ: Treatment of clomipramine-induced anorgasmia with yohimbine: A case report. J Clin Psychiatry 1990;51:32-33.
19. Bartlik BD, Kaplan HS: Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J Sex Marital Ther 1995;21:264-271.
20. Boolell M, Allen MJ, Ballard SA, Gepi-Attee S, Muirhead GJ, Naylor AM, Osterloh IH, Gingell C: Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996;8:47-52.
21. Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ: Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992;326:90-4.
22. Andersson KE, Wagner G: Physiology of penile erection. Physiol Rev 1995;75:191-236.
23. Burnett AL: The role of nitric oxide in the physiology of erection. Biol Reprod 1995;52: 485-489.
24. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA: Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998;338:1397-1404.
25. Segraves K, Segraves RT: Guided Interview Questionnaire for females and males; in Intimacy and Depression - The Silent Epidemic. Roundtable Proceedings, Washington, March 11, 1998.
26. McGahuey CA, Gelenberg AJ, Laukes CA, Manber R, McKnight KM, Moreno FA, Delgado PL: The Arizona Sexual Experience Scale: Validity and reliability. Proceedings of the Annual Meeting of the American Psychiatric Association, San Diego, May 17-22, 1997.